Farmacia italiana online: acquisto cialis in Italia e Roma senza ricetta.

Monomerpolymer.com

MATERIAL SAFETY DATA SHEET
Section 1 - Chemical Product and Company Identification
Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-monohydrochloride, monohydrate MONOMER-POLYMER & DAJAC LABORATORIES EMERGENCY TELEPHONE NUMBER (CHEMTREC): (800) 424-9300 or (703) 527-3887 Section 2 - Composition / Information on Ingredients
CAS NUMBER
HAZARDOUS COMPONENT
Section 3 - Hazards Identification

ROUTE(S) OF ENTRY: Eyes, skin, inhalation and ingestion.
HEALTH HAZARDS (ACUTE AND CHRONIC):
EYES:
May cause respiratory system irritation.
SIGNS OF OVEREXPOSURE:

MATERIAL SAFETY DATA SHEET

OTHER HEALTH WARNINGS: None noted
Section 4 - First Aid Measures
Remove contact lenses immediately. Wash with copious amounts of water for at least 15 minutes. Do not rub eyes. Seek medical attention immediately. SKIN CONTACT: Wash throroughly with soap and water. Remove contaminated clothing. If symptoms persist, call a Move to fresh air. Seek medical attention. If swallowed, immediately drink a large quantity of water and call a physician. Section 5 - Fire-Fighting Measures
FLASH POINT: N/E
FLAMMABLE LIMITS:

EXTINGUISHING MEDIA:

Dry chemical, carbon dioxide for small fires. Foam and fog should be used for large fires. Water fogs should be used to cool containers exposed to extreme heat from side . SPECIAL FIRE FIGHTING PROCEDURES:
Use self-contained breathing apparatus and full protective clothing in confined areas.
UNUSUAL FIRE FIGHTING PROCEDURES:

In finely divided dust form, material is assumed to be combustible. As with all dry powders it is advisable to ground mechanical equipment in contact with dry material to dissipate the potential build-up of static electricity. Emits toxic fumes under fire conditions. Section 6 - Accidental Release Measures
STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED:
FOR LARGE SPILLS: Evacuate area and ventilate. Stay upwind. Eliminate ignition sources. Lay down inert
absorbent material such as diatomaceous earth or vermiculite, dike to control spill if necessary. Using recommended protective equipment, pick up bulk of spill and containerize for recovery or disposal. Flush area with water to remove residues. MATERIAL SAFETY DATA SHEET
Section 7 - Handling and Storage
PRECAUTIONS TO BE TAKEN IN HANDLING AND STORAGE:
Store in a tightly closed container in a dry, cool area. Avoid contact with material. Avoid prolonged or repeated exposure. Lab should be equipped with a safety shower and an eye wash station. Wash thoroughly after handling material. Keep away from heat and open flames. Material should only be handled by qualified, experienced professionals.
OTHER PRECAUTIONS:
Section 8 - Exposure Controls / Personal Protection
VENTILATION REQUIREMENTS:
Ventilation should be designed in accordance with good engineering practices.
PERSONAL PROTECTIVE EQUIPMENT:

RESPIRATORY PROTECTION: Wear appropriate NIOSH/MSHA-approved respirator with organic vapor cartridge
Splashproof goggles or face shield (ANSI Z87.1 or approved equivalent). DERMAL PROTECTION: Protect all exposed skin from contact. Use gloves or neoprene or other chemically inert material. Use chemically resistant apron or other chemically impervious clothing to avoid prolonged or repeated skin contact. Eyewash and safety showers should be available in areas where this product is handled. Section 9 - Physical and Chemical Properties
SOLUBILITY IN WATER:
SPECIFIC GRAVITY (H2O = 1)
APPEARANCE AND ODOR:
BOILING POINT (760 mm Hg)
MELTING POINT:
Section 10 - Stability and Reactivity

STABILITY:


HAZARDOUS DECOMPOSITION OR BY-PRODUCTS:

Oxides of carbon and nitrogen, hydrogen chloride.
HAZARDOUS POLYMERIZATION:


INCOMPATIBILITY:
CONDITIONS TO AVOID:
MATERIAL SAFETY DATA SHEET
Section 11 - Toxicological Information

ACUTE EYE EFFECTS:
Section 12 - Ecological Information

No information available

Section 13 - Disposal Considerations

WASTE DISPOSAL METHOD:

If reclamation is not possible, dispose of material in accordance with all Federal, State and Local regulations. Section 14 - Transport Information

DOT TRANSPORTATION DATA*
:
PROPER SHIPPING NAME:
*Contact Monomer-Polymer & Dajac Labs for details. Section 15 - Regulatory Information
RCRA STATUS: Not subject to the 40CFR part 268.30 land ban on the disposal of certain hazardous wastes. SARA TITLE III STATUS: SECTION 311/312: Not listed. SECTION 313: MATERIAL SAFETY DATA SHEET
Section 16 - Other Information
ADDITIONAL MANUFACTURER WARNINGS:
Store only in closed, properly labeled containers.
Do not use cutting or welding torches on drums, which contained this product unless they have been properly
cleaned and purged.
Use only with adequate ventilation.
Do not eat, drink or smoke in work areas. Wash hands with soap and water prior to eating or using toilet facilities
and at the end of the work shift. Launder contaminated clothing prior to reuse.


OTHER PRECAUTIONS AND COMMENTS:
PREVIOUS REVISION DATE: N/A = Not Applicable N/D = Not Determined N/E = Not Established S ST = Short Term Exposure Limit Information contained herein is correct and accurate to the best of Monomer-Polymer & Dajac Laboratories knowledge and pertains only to materials purchased from Monomer-Polymer and Dajac Labs. Monomer-Polymer & Dajac Labs makes no warranty, oral or written, expressed or implied, of merchantability or fitness for a particular purpose regarding this product or its use. Purchaser assumes all risks of use, application, and handling.

Source: http://monomerpolymer.com/uploads/MSDS%206286%20Lidocaine%20Hydrochloride.pdf

Z:\nepss\arq_doc\dis_duchenne.prn.pdf

DISTROFIA MUSCULAR DE DUCHENNE: COMPLICAÇÕES RESPIRATÓRIAS E SEU TRATAMENTO DISTROFIA MUSCULAR DE DUCHENNE: COMPLICAÇÕES RESPIRATÓRIAS E SEU TRATAMENTO Trabalho apresentado para fins de avaliação parcial na disciplina Trabalho de Conclusão de Curso II do Curso de Fisioterapia da Universidade Católica de Goiás. Orientadora: Profª Drª Fábia Maria Oliveira Pinho D

torii.co.jp

Pfizer Inc 235 East 42nd Street New York, NY 10017-5755 VIRACEPT® (nelfinavir mesylate) 250 mg, 625 mg tablets, and Powder for Oral Suspension IMPORTANT INFORMATION FOR PRESCRIBERS The purpose of this letter is to inform you that Pfizer and FDA have agreed on a final limitfor ethyl methane sulfonate (EMS) in nelfinavir mesylate (active ingredient in Viracept®) and to provide guidance on

Copyright © 2010-2014 Pdf Pills Composition